Cargando…
A novel landscape of nuclear human CDK2 substrates revealed by in situ phosphorylation
Cyclin-dependent kinase 2 (CDK2) controls cell division and is central to oncogenic signaling. We used an “in situ” approach to identify CDK2 substrates within nuclei isolated from cells expressing CDK2 engineered to use adenosine 5′-triphosphate analogs. We identified 117 candidate substrates, ~40%...
Autores principales: | Chi, Yong, Carter, John H., Swanger, Jherek, Mazin, Alexander V., Moritz, Robert L., Clurman, Bruce E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164936/ https://www.ncbi.nlm.nih.gov/pubmed/32494624 http://dx.doi.org/10.1126/sciadv.aaz9899 |
Ejemplares similares
-
Fbw7 dimerization determines the specificity and robustness of substrate degradation
por: Welcker, Markus, et al.
Publicado: (2013) -
Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
por: Welcker, Markus, et al.
Publicado: (2022) -
Identification of CDK2 substrates in human cell lysates
por: Chi, Yong, et al.
Publicado: (2008) -
Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase
por: Grim, Jonathan E., et al.
Publicado: (2008) -
CDK Substrate Phosphorylation and Ordering the Cell Cycle
por: Swaffer, Matthew P., et al.
Publicado: (2016)